
-
What are regulatory T-cells? Nobel-winning science explained
-
Indirect talks on ending Gaza war begin in Sharm El-Sheikh: Egypt media
-
OpenAI signs multi-billion dollar chip deal with AMD
-
Salah under fire as Liverpool star loses his spark
-
Paris stocks drop as French PM resigns, Tokyo soars
-
ICC finds Sudan militia chief guilty of crimes against humanity
-
Zverev dumped out of Shanghai Masters by France's Rinderknech
-
One hiker dead, hundreds rescued after heavy snowfall in China
-
Hundreds stage fresh anti-government protests in Madagascar
-
Feminist icon Gisele Pelicot back in court as man appeals rape conviction
-
US government shutdown enters second week
-
Kasatkina ends WTA season early after hitting 'breaking point'
-
Paris stocks drop as French PM resigns
-
Death toll from Indonesia school collapse rises to 63
-
Medicine Nobel to trio who identified immune system's 'security guards'
-
UN rights council launches probe into violations in Afghanistan
-
UK author Jilly Cooper dies aged 88
-
Jilly Cooper: Britain's queen of the 'bonkbuster' novel
-
Streaming stars' Le Mans race scores Twitch viewer record
-
England rugby star Moody 'shocked' by motor neurone disease diagnosis
-
Leopard captured after wandering into Indonesian hotel
-
Israel, Hamas due in Egypt for ceasefire talks
-
Rescuers scramble to deliver aid after deadly Nepal, India floods
-
Tokyo stocks soar on Takaichi win, Paris sinks as French PM resigns
-
OpenAI offers more copyright control for Sora 2 videos
-
Australia prosecutors appeal 'inadequate' sentence for mushroom murderer: media
-
Rugby World Cup-winning England star Moody has motor neurone disease
-
Trump says White House to host UFC fight on his 80th birthday
-
Vast reserves, but little to drink: Tajikistan's water struggles
-
US government shutdown may last weeks, analysts warn
-
Arsenal host Lyon to start new Women's Champions League format
-
Gloves off, Red run, vested interests: Singapore GP talking points
-
Bills, Eagles lose unbeaten records in day of upsets
-
Muller on target as Vancouver thrash San Jose to go joint top
-
Tokyo soars, yen sinks after Takaichi win on mixed day for Asia
-
China's chip challenge: the race to match US tech
-
UN rights council to decide on creating Afghanistan probe
-
Indonesia sense World Cup chance as Asian qualifying reaches climax
-
ICC to give war crimes verdict on Sudan militia chief
-
Matthieu Blazy to step out as Coco's heir in Chanel debut
-
Only man to appeal in Gisele Pelicot case says not a 'rapist'
-
Appetite-regulating hormones in focus as first Nobel Prizes fall
-
Gisele Pelicot: French rape survivor and global icon
-
Negotiators due in Egypt for Gaza talks as Trump urges quick action
-
'My heart sank': Surging scams roil US job hunters
-
Competition heats up to challenge Nvidia's AI chip dominance
-
UK police to get greater powers to restrict demos
-
Valsoft Corporation Announces Creation of Operating Groups to Strengthen Portfolio Management and Long-Term Growth
-
Form Bio and Cure Rare Disease Partner to Accelerate Genetic Medicine Development, Advancing CRD's Duchenne Muscular Dystrophy Program
-
A $1 SIM Card Nearly Triggered America's Zero Day; Here's How SMX Could Stop the Next Attempt (NASDAQ: SMX)
RIO | 1.72% | 67.265 | $ | |
CMSC | -0.32% | 23.795 | $ | |
BTI | -0.41% | 51.03 | $ | |
SCS | -0.44% | 17.035 | $ | |
BCE | -0.73% | 23.19 | $ | |
NGG | 0% | 73.43 | $ | |
CMSD | -0.1% | 24.426 | $ | |
RBGPF | -2.92% | 76 | $ | |
BCC | -1.4% | 76.56 | $ | |
JRI | -0.48% | 14.231 | $ | |
GSK | 1.08% | 43.825 | $ | |
AZN | 0.84% | 86.03 | $ | |
RYCEF | -0.7% | 15.65 | $ | |
VOD | -0.68% | 11.283 | $ | |
RELX | 0.48% | 46.635 | $ | |
BP | 2.27% | 34.952 | $ |

Releaf Acquires Domain Releaf.com for £110,000
The UK's fastest-growing medicinal cannabis clinic begins international strategy with further online investment.
NOTTINGHAM, ENGLAND / ACCESS Newswire / September 2, 2025 / Releaf, the UK's fastest-growing medicinal cannabis clinic, has acquired the domain Releaf.com for £110,000 as part of its global expansion strategy. The move comes as the company overtakes £2.1 million in monthly revenue and prepares to take its proven healthcare model to international markets.
Releaf's technology platform, fully integrated with the NHS Spine, now serves over 300,000 unique website visitors monthly. The platform uses AI-assisted triage to match patients with specialist prescribers and delivers doctor-led care directly to patients' doors, effectively removing traditional barriers to access.
Jon Dunn, Marketing Director at Releaf, explains, "Releaf.com is our launchpad for global growth. This isn't just a domain, it's our passport to every market we enter. It gives us instant credibility, makes our brand unforgettable, and ensures patients worldwide know exactly where to find us."
The company has achieved significant growth in the UK market, onboarding over 120 new patients daily and conducting more than 300 consultations each day. This momentum is driving substantial expansion, with plans to double clinical operations month-on-month to reach over 6,000 initial consultation slots per month by year end.
Having demonstrated its approach works in the UK's highly regulated healthcare environment, Releaf is now positioning its technology-led model for international rollout. The company is targeting markets where patients face similar structural challenges in accessing cannabinoid healthcare.
Releaf continues to reinvest into clinician onboarding, patient support, and platform enhancements, ensuring high standards of care while building capacity for international expansion. With European operations already underway, the company is well-positioned to become a leading provider of regulated cannabinoid healthcare globally.
About Releaf
Launched in 2024, Releaf Dispensary Ltd the UK's fastest-growing and most-trusted* medical cannabis clinic, serving patients through its advanced healthtech platform. With a prescriber network of over 40 specialists, we deliver evidence-based cannabinoid care directly to patients' homes through tailored treatment plans.Fully integrated with NHS systems, Releaf has transformed access to medicinal cannabis treatment in the UK and is now expanding internationally. *According to Trustpilot.
Media Contact: Sophie Stephen, Marketing Manager, [email protected]
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: Releaf Dispensary Ltd
View the original press release on ACCESS Newswire
A.Malone--AMWN